ACU193: An Immunotherapeutic Poised to Test the Amyloid β Oligomer Hypothesis of Alzheimer’s Disease

Alzheimer’s disease (AD) is an age-related neurodegenerative disease that affects 50 million people worldwide, with 10 million new cases occurring each year. The emotional and economic impacts of AD on patients and families are devastating. Approved treatments confer modest improvement in symptoms,...

Descripción completa

Detalles Bibliográficos
Autores principales: Krafft, Grant A., Jerecic, Jasna, Siemers, Eric, Cline, Erika N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9088393/
https://www.ncbi.nlm.nih.gov/pubmed/35557606
http://dx.doi.org/10.3389/fnins.2022.848215

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9088393/
https://www.ncbi.nlm.nih.gov/pubmed/35557606
http://dx.doi.org/10.3389/fnins.2022.848215

Ejemplares similares